Category: Access to Medicine

Access to Medicine, Patents

The Price Isn’t Right: Sen. Warren’s Antidote to Costly Medicine

When I tell you the cost of many medications in America is prohibitively expensive, you likely aren’t surprised. Access to medicine and drug costs has been a major topic of debate for a long time. Most recently, U.S. politicians and pharma industry leaders have stoked the fiery debate on healthcare costs in response to the National Institute of Health’s (NIH) rejection for a petition to grant march-in rights for a prostate cancer medication called, Xtandi®. To learn more about march-in rights and the recent concern over the drug, Xtandi®, read High Drug Prices: Meet Bayh-Dole.
Continue reading “The Price Isn’t Right: Sen. Warren’s Antidote to Costly Medicine”

Bailey Hammond
Access to Medicine, Patents

High Drug Prices: Meet Bayh-Dole

Imagine this: you have just been diagnosed with cancer. The diagnosis is serious, and if untreated, will end your life. But good news – there is a lifesaving treatment available! It will just cost you $150,000 a year. Not only are you left with the emotional stress of a serious diagnosis, but now have the added financial stress of the unaffordable price tag that comes with the treatment. Is there anything that can be done to make the treatment more affordable? Continue reading “High Drug Prices: Meet Bayh-Dole”

Hannah Dawson
Access to Medicine, Patents

In the Market for Affordable Medicines

Patents and pandemics.  At first, these two things might not seem too related.  Beyond patenting useful things for a pandemic – personal protective equipment, medicines, etc. – what do they have to do with one another?  Well, it turns out that the COVID-19 pandemic has put the spotlight on how to make patented medicines affordable.

Continue reading “In the Market for Affordable Medicines”

Scott Hulver
Access to Medicine, Patents

An Evolving View on Access to Affordable Medicine

Rising drug prices have led to major issues with providing broad access to medicine around the world. While these issues receive significant media attention, it is important to understand fully why these problems exist in order to come up with real solutions. My perspective is shaped in large part by my background as a scientist. As a researcher, I viewed the issue purely through a scientific lens. I was focused on how to improve the drug development process through the technologies we were creating. However, I realized that there were also legal issues constraining technology development that spurred my interest in attending law school to pursue a career in patent law. As a first-year law student, my perspective has already broadened. I now know about legal barriers that can inhibit the impact of those technologies on global access to improved and cheaper medicine.

Continue reading “An Evolving View on Access to Affordable Medicine”

Bradley Loren